Trial Profile
Phase I trial of BTP 277 in patients with cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs BTP 277 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Tarveda Therapeutics
- 15 Apr 2015 New trial record
- 13 Apr 2015 Blend Therapeutics plans to file an IND application for this trial with the US FDA in early 2016, according to a media release.